People that are receiving cyclosporine, tacrolimus or other agents to forestall graft-compared to-host ailment submit bone marrow transplant will not be qualified for this trial Experimental: Dose expansion_sub-inhabitants 2_lower dose of niraparib MTDs and/or prospect RP2Ds for elimusertib made use of together with niraparib in a lower set dose. MICU1-deficient https://cgp78608hydrochloride68024.bloginder.com/27283221/manual-article-review-is-required-for-this-article